2022
DOI: 10.3389/fendo.2022.927390
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential

Abstract: The tumor microenvironment fuels tumorigenesis and induces the development of resistance to anticancer drugs. A growing number of reports support that the tumor microenvironment mediates these deleterious effects partly by overexpressing insulin-like growth factor 1 (IGF-1). IGF-1 is known for its role to support cancer progression and metastasis through the promotion of neovascularization in transforming tissues, and the promotion of the proliferation, maintenance and migration of malignant cells. Anti-IGF th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 79 publications
0
14
0
Order By: Relevance
“…Therefore, this axis is a potential target for multiple lines of therapy, being incriminated also in tumor resistance and invasiveness. Silencing the IGF pathway has shown promising results in preclinical trials, albeit with significant challenges [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, this axis is a potential target for multiple lines of therapy, being incriminated also in tumor resistance and invasiveness. Silencing the IGF pathway has shown promising results in preclinical trials, albeit with significant challenges [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…IGF1R plays a crucial role in cell biology processes such as cell proliferation, metabolism, and tumor development by activating downstream signaling pathways upon binding to insulin‐like growth factor 1 (IGF‐1) or insulin‐like growth factor 2 (IGF‐2) 37,38 . Recently, IGF1R has been reported to promote cancer metastasis and drug resistance 39,40 . Patients with high IGF1R expression tend to have shorter overall survival and a higher possibility of metastasis in various types of cancer, such as breast cancer, prostate cancer, and lung cancer 41–43 .…”
Section: Discussionmentioning
confidence: 99%
“…The direct effects are linked to the activation of the PI3K/AKT/mTORC1 signaling pathway, stimulated by IGF-1 and IGF-1 receptor (IGF1R) activation. Activation of this signaling pathway increases mitogenesis and cell cycle progression but protects against different apoptotic stresses [ 58 , 59 ]. Sustained proliferation and evading apoptosis are critical hallmarks of cancers [ 60 ].…”
Section: Potential Milk-related Factors Promoting Dlbclmentioning
confidence: 99%